Alliant provides Medication Assisted Treatment (MAT) to help clients in their recovery. MAT is an evidence-based method of treatment that uses medical interventions and substance abuse counseling and social support to enable clients in their recovery effort.
MAT is one of the most effective and life-changing forms of care that can help chemical-dependent individuals overcome the urge to engage in substance abuse. This intervention is designed specifically for the treatment of drug addictions.
Suboxone Subutex Vivatol
Opioid addiction is a chronic, relapsing brain disease that affects people psychologically and physically. Effective treatment programs often focus on both aspects of addiction through counseling and medication. VIVITROL is a non-addictive, once-monthly treatment proven to prevent relapse in opioid dependent patients when used with counseling following detoxification. VIVITROL blocks opioid receptors in the brain while you work with the psychological aspects of counseling.
TREATING OPIOID DEPENDENCE WITH VIVITROL AND COUNSELING
When used as part of a treatment plan that includes counseling, VIVITROL can help prevent relapse to opioid dependence after detox.
During a 6-month, double-blind, placebo-controlled, randomized clinical study, compared to opioid-dependent patients being treated with a placebo and counseling (n=124), opioid-dependent patients being treated with VIVITROL and counseling (n=126):
VIVITROL® (naltrexone for extended-release injectable suspension):
· Once-monthly injection
· Non-addictive
VIVITROL IS USED:
To help prevent relapse to opioid dependence after detox
To treat alcohol dependence. You should stop drinking before starting VIVITROL
· Before starting VIVITROL, you must be opioid-free for a minimum of 7-14 days to avoid sudden opioid withdrawal
· VIVITROL must be used with other drug or alcohol recovery programs such as counseling
For opioid dependence: SUBOXONE® (buprenorphine and naloxone) Sublingual Film (CIII)
Opioid dependence treatment
You are not alone. In 2016, there were approximately 2.1 million people† that had abused or were dependent on opioids—such as heroin—or prescription painkillers.
Find a treatment provider here, who can provide treatment closest to where you live.
The Substance Abuse and Mental Health Services Agency (SAMHSA) also provides treatment information at http://www.samhsa.gov/find-help
Suboxone – SUBOXONE Film is approved for use in both induction and maintenance treatment of opioid dependence in appropriate patients.
· For dependence on short-acting opioids, like heroin or prescription painkillers, SUBOXONE Film, which contains buprenorphine and naloxone, may be recommended to help you begin and maintain continuity of treatment
· When transitioning from dependence on long-acting opioids, like methadone, a buprenorphine-only medication may be recommended
If a doctor, nurse practitioner or physician assistant waivered to treat opioid dependence prescribes SUBOXONE Film, your treatment can begin. The following are potential stages of treatment with SUBOXONE Film. Only your healthcare provider can decide what is an appropriate treatment plan for you.
1. Induction—you begin your treatment (or restart it if you’ve relapsed) under the supervision of a healthcare provider. For your first dose, you must be in a moderate state of withdrawal. You work with your healthcare provider to reach a dose of SUBOXONE Film that works for you.
2. Maintenance—Your healthcare provider will help you to transition to the maintenance phase of treatment when you:
o Are no longer experiencing withdrawal symptoms
o Have minimal to no side effects
o Do not have uncontrollable cravings
In the maintenance phase, you may be taking your medication regularly as prescribed. You should comply with all of the elements in your treatment plan including responsibly handling the medication, staying free from illicit drug use, and seeking counseling and/or psychosocial support.
3. Medical taper—The decision to discontinue therapy with SUBOXONE Film after a period of maintenance should be made as part of a comprehensive treatment plan. It is important that you work with your doctor, nurse practitioner or physician assistant to determine when the time is right to slowly lower your dose, taking care to minimize withdrawal symptoms. Throughout treatment, you should discuss any concerns you have about relapse with your healthcare provider.
Subutex is an opioid-derived medication that is routinely used in the treatment of addiction to other opiates, such as heroin and prescription opioid pain relievers.
Released in 1982, this form of buprenorphine was launched as Subutex, a sublingual form of the drug that dissolves under the tongue. Initially, it was promoted as a pain reliever too.
Later, it would evolve into the treatment drug it is known to be. Subutex was especially recommended for its lower likelihood of abuse. Subutex in its sublingual form was discontinued in 2012 in the US, though it is still available in generic form.
What Is It Used For?
Today, Subutex is used solely for its treatment purposes in helping people wean off other opiates. The active ingredient in Subutex – buprenorphine – has been noted as having an 88 percent success rate among people who use it for this reason, per The Fix.
Subutex / Buprenorphine is the generic form of Subutex, a prescription drug used to treat dependence on opioid painkillers such as oxycodone (OxyContin). It’s also prescribed in lower dosages to treat pain.
If you are recovering from surgery, your doctor may start you on buprenorphine to treat your post-operative pain. The drug works on your nervous system and in your brain to reduce the way you feel pain.
Buprenorphine is also used in the treatment of some narcotic drug addictions. When it is used for this purpose, buprenorphine is often combined with naloxone, an ingredient that counters the effects of an overdose of buprenorphine. This combination drug, called Suboxone, is normally given in the privacy and safety of a doctor’s office.